Every individual living with type 1 diabetes understands the discipline the condition demands. Even minor deviations can ...

Chief Medical Officer Trang Ly said the system, which allows people to manage Type 2 diabetes without bolusing, will be ...

Please provide your email address to receive an email when new articles are posted on . Of 20 hospitals providing insulin algorithms, 60% stated which patients should initiate basal or nutritional ...

MiniMed (Nasdaq:MMED) announced that it kicked off its first commercial launch of its Flex automated insulin delivery system ...

A University of Virginia Center for Diabetes Technology-developed algorithm – paired with a continuous glucose monitor – can help users better manage their type 2 diabetes by recommending insulin-dose ...

Diabeloop receives FDA 510(k) clearance for DBLG2, an Automated Insulin Delivery algorithm in an App: a strategic turning point. The company confirms its status as a global reference partner for ...

Compared to regular human insulin, five faster-acting insulin analogues may offer similar benefits in controlling blood glucose levels. Compared to regular human insulin, some of them (ultra-rapid ...

A new therapy for type 1 diabetes could nix the need for insulin injections. Just a single infusion of lab-grown pancreatic cells let patients’ bodies make all the insulin they needed, scientists ...

Leo, a 22-year-old man who received a diagnosis of type 1 diabetes at 17 years of age, has struggled to meet glucose targets. As a young adult, he has many competing priorities, and diabetes is not ...

Share on Pinterest Mounjaro appears to be a safe and effective adjunct therapy to slow-release insulin for treating uncontrolled diabetes. Mohammed Al Ali/Shutterstock Tirzepatide, Mounjaro, is ...